These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7189

  • 21. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T, Neu HC.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [Abstract] [Full Text] [Related]

  • 22. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
    Minguez F, Ramos C, Loscos A, Chiu ML, Prieto J.
    Chemotherapy; 1993 Apr; 39(3):163-8. PubMed ID: 8389685
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ, Chanal M, Kitzis MD, Duval J, Cluzel R, Acar JF.
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E, Mannelli S, Gianrossi G, Schito GC.
    Drugs Exp Clin Res; 1987 Feb; 13(4):213-7. PubMed ID: 3304918
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY, Sutter VL, Oberhammer I, Finegold SM.
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract] [Full Text] [Related]

  • 29. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ, Mehtar S, Blakemore PH.
    Drugs Exp Clin Res; 1987 Jan; 13(4):201-3. PubMed ID: 3622250
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L, Devos J, Romond C, Bryskier A.
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [Abstract] [Full Text] [Related]

  • 32. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
    Speciale A, Musumeci R, Blandino G, Milazzo I, Caccamo F, Nicoletti G.
    Int J Antimicrob Agents; 2002 Feb; 19(2):111-8. PubMed ID: 11850163
    [Abstract] [Full Text] [Related]

  • 33. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA, Knothe H, Koulen G.
    Drugs Exp Clin Res; 1987 Feb; 13(9):567-76. PubMed ID: 2962847
    [Abstract] [Full Text] [Related]

  • 34. [Josamycin: antibacterial activity against anaerobes (author's transl)].
    Watanabe K, Watanabe I, Ezaki T, Kobata S, Imamura H, Ninomiya K, Ueno K, Suzuki S.
    Jpn J Antibiot; 1978 Aug; 31(8):487-92. PubMed ID: 702806
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
    Hamilton-Miller JM.
    J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
    [Abstract] [Full Text] [Related]

  • 37. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark.
    Salmon SA, Watts JL, Aarestrup FM, Pankey JW, Yancey RJ.
    J Dairy Sci; 1998 Feb; 81(2):570-8. PubMed ID: 9532511
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.